Records containing: Huntington's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-02-03A Phase 1, Fixed Sequence, Cross-Over Study To Investigate The Single Dose Pharmacokinetics Of A Dimebon (Latrepirdine) Transdermal Solution Relative To The Immediate Release Formulation In Older Adults
-
CLINICAL_TRIALS study record update · 2009-12-30A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
-
CLINICAL_TRIALS study record update · 2009-11-18A Phase I, Open-Label, Three-Period, Fixed-Sequence Study To Estimate The Steady-State Effect Of Ketoconazole And Omeprazole On The Single-Dose Pharmacokinetics Of Dimebon [PF-01913539] In Healthy CYP2D6 EM And PM Subjects
-
CLINICAL_TRIALS study record update · 2008-03-04NMDA-Receptor Blockade in Huntington's Chorea
-
CLINICAL_TRIALS study record update · 2008-03-04Stimulation of Tyrosine Kinase and ERK Signaling Pathways in Huntington's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-01-04A Multicenter, Phase 1-2A, Open-Label, Dosage-Escalation and Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2006-08-18Creatine Therapy for Huntington's Disease